Riskpilot← Back to searchSign inGet full accessAPOTEKERGADEN 9 A + 9 B AS
ASActiveOrg 993038601Korsegata 8, 6002 ÅlesundRental and operating of own or leased real estate · NACE 6820Est. 20080 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 64K
+90% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 64K | +90% |
| Total assets | NOK 3M | +2% |
| Equity | NOK 3M | +2% |
| Employees | 0 | — |
Legal name
APOTEKERGADEN 9 A + 9 B AS
Org number
993038601
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
3. september 2008
Share capital
NOK 1 800 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Delta som komplementar i apotkergaden 9 a + b ks og det som følger naturlig av en slik deltakelse.
Address
Korsegata 8, 6002 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −12 | −11 | −10 | −11 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −12 | −11 | −10 | −11 | 0 |
| Net financials | 23 | 20 | 20 | 20 | 26 |
| Profit before tax | 10 | 9 | 10 | 10 | 26 |
| Tax | −86 | −14 | −25 | −24 | −38 |
| Net profit | 96 | 23 | 36 | 33 | 64 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 821 | 2 847 | 2 880 | 2 922 | 2 977 |
| Equity | 2 821 | 2 844 | 2 880 | 2 913 | 2 977 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 3 | 0 | 9 | 0 |
| Total debt | 0 | 3 | 0 | 9 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
6354700.0%
This company
8.1%
Market median
+78452986% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BK Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Board of Directors | 2022 – 2024 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ktf Holding As
APOTEKERGADEN 9 A + 9 B AS Board members of APOTEKERGADEN 9 A + 9 B AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Berit Kristin Westad | Chief Executive Officer | 0 companies |
| Carl Magnus Hegde Næss | Chairman | 0 companies |
| Knut Trygve Flakk | Board of Directors | 0 companies |
| Jon Ketil Gjørtz | Chairman | 0 companies |
| Malin Gjørtz | Chairman | 0 companies |
| Henning Tangen Veibust | Board of Directors | 0 companies |
| Lasse Viken Kjønstad | Board of Directors | 0 companies |